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Donghwan Kim2, Shang Jia6, Christopher J. Chang 6, Heejung Yang 2,8, Tomokazu Nagano2,9,
Kristopher W. Krausz2, Sun-Hee Yim2,10 & Frank J. Gonzalez 2 ✉

The environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) causes hepatic
toxicity associated with prominent lipid accumulation in humans. Here, the authors report
that the lysosomal copper transporter SLC46A3 is induced by TCDD and underlies the
hepatic lipid accumulation in mice, potentially via effects on mitochondrial function. SLC46A3
was localized to the lysosome where it modulated intracellular copper levels. Forced
expression of hepatic SLC46A3 resulted in decreased mitochondrial membrane potential and
abnormal mitochondria morphology consistent with lower copper levels. SLC46A3 expression increased hepatic lipid accumulation similar to the known effects of TCDD exposure in
mice and humans. The TCDD-induced hepatic triglyceride accumulation was signiﬁcantly
decreased in Slc46a3−/− mice and was more pronounced when these mice were fed a highfat diet, as compared to wild-type mice. These data are consistent with a model where
lysosomal SLC46A3 induction by TCDD leads to cytosolic copper deﬁciency resulting in
mitochondrial dysfunction leading to lower lipid catabolism, thus linking copper status to
mitochondrial function, lipid metabolism and TCDD-induced liver toxicity.
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onalcoholic fatty liver disease (NAFLD) is one of the most
common chronic liver diseases in developed countries1.
Fatty liver can be caused by diet, drugs, viruses, genetic
factors, hormones, or environmental pollutants2. Hepatic lipid
accumulation can lead to nonalcoholic steatohepatitis, cirrhosis,
liver failure, and hepatocellular carcinoma. Abnormal hepatic
lipids can also be caused by chemically-induced toxicity by
compounds like dioxins that are constituents of environmental
pollution that threaten the ecosystem and exist as complex isomers of aromatic halogen compounds3. The most poisonous
toxicant among the dioxins is 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD), a major contaminant in Agent Orange, an herbicide
used in the Vietnam War between 1962 and 1971 to destroy
forests for military purposes. TCDD is also produced during
incomplete combustion of organic materials. Accidental exposure
to dioxins induces tissue-speciﬁc toxicity with decreased immune
function, increased hepatic drug metabolizing-enzyme induction,
teratogenesis, thymic degeneration, cirrhosis, endocrine disruption, infertility, liver toxicity associated with increased lipid
accumulation, and cancer4,5.
TCDD toxicity is due to its ability to activate the aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor
that is activated by xenobiotics including dioxins and polycyclic
aromatic hydrocarbons6. The molecular mechanisms of many
speciﬁc toxicities elicited by TCDD exposure are still not fully
understood. In experimental animal models, these effects are due
to activation of the AhR. The AhR nuclear translocator (ARNT)
and ligand-bound AhR form a heterodimer that binds to elements in the promoter regions of target genes and activates
transcription7,8.
The function of solute carrier 46a3 (SLC56A3) is not known.
Slc46a3 mRNA, similar to the AhR-regulated Cyp1a2 mRNA, is
constitutively expressed in livers of wild-type mice and upon
treatment with TCDD, was induced with similar kinetics to
Cyp1a2 mRNA; induction of both mRNAs was not found in Ahrnull and Arnt liver-speciﬁc conditional-null mice. In view of the
effects of TCDD on hepatic steatosis, it was of interest to determine whether SLC46A3 expression and its induction by
AhR, affects hepatic lipid levels. While phylogenetically SLC46A3
is a solute carrier, its function and substrate(s) are unknown.
Thus, the function of SLC46A3 and it role in liver lipid homeostasis was studied using Slc46a3−/− mice, cultured primary
hepatocytes, and forced expression of recombinant SLC46A3 in
cultured cells. Induction of lysosomal SLC46A3 by TCDD
induces intracellular copper deﬁciency, which results in mitochondrial dysfunction resulting in lower lipid catabolism
and hepatic lipid accumulation.
Results
Lysosomal SLC46A3 is regulated by AhR. Slc46a3 mRNA was
induced by TCDD in the mouse liver while no induction was
found in kidney or different regions of the small intestine and the
colon, where constitutive Slc46a3 mRNA was detected, indicating
liver-speciﬁc induction by the AhR (Fig. 1a). This is a similar
pattern of induction found with another AhR target gene Cyp1a2,
which shows liver-speciﬁc induction. Both Slc46a3 and Cyp1a2
mRNAs were induced in an AhR-dependent manner since no
induction was found in Ahr−/− and ArntΔLiv mice (Fig. 1a, b). As
a negative control for TCDD, the non-dioxin-like polychlorinated
biphenyl-153 (PCB-153) was analyzed by extraction of Gene
Expression Omnibus (GEO) data sets (accession: GSE55084), and
no induction of Slc46a3 mRNA was noted (Fig. 1c)9.
Putative DRE sites were found in a published ChIP-seq data set
(GEO, accession: GSE97634) (Fig. 1d, e). A potential remote DRE site
−17,135 bp of upstream of Slc46a3 was examined for trans-activation
2

by AhR and TCDD using luciferase reporter gene assays, revealing
that 3×DRE-luciferase activity was signiﬁcantly increased by 10 nM
TCDD in Hepa1c1c7 cells and was abolished by mutation of the
DRE site (Fig. 1f) and CH-223191, an AhR antagonist (Fig. 1g).
Likewise, CH-223191 suppressed TCDD-induced Slc46a3 mRNA
levels (Fig. 1h). These results suggest that AhR may be functioning
through a DRE located in a remote long-range enhancer controlling
AhR activation of the Slc46a3 gene.
Time and dose-dependent expression of Slc46a3 mRNA
induction by TCDD. In mouse liver, Slc46a3 mRNA was
developmentally gradually increased up to 8 weeks of age (Fig. 1i).
In addition, Slc46a3 mRNA was elevated seven fold by 10 μg/kg
TCDD in a time-dependent manner over 24 h (Fig. 1j). No signiﬁcant loss of Slc46a3 mRNA levels was noted after 3 days and
expression persisted for 7 days (Fig. 1k). This might be due to the
high afﬁnity of TCDD to AhR and its persistent activation, or due
to a very stable Slc46a3 mRNA that, once induced, does not
rapidly decay.
Generation and phenotype of Slc46a3−/− mice. To explore a
role for SLC46A3 in the liver, Slc46a3−/− mice were generated
(Fig. 2a–c). The mice were born at the expected frequency,
showed no developmental defects, and no gross abnormal phenotype, as compared to matched wild-type controls. A striking
color change was noted in the livers of Slc46a3−/− mice compared to wild-type mice. Notably, the livers of Slc46a3−/− mice
were darker, and, after perfusion with saline, showed a more
grayish color (Fig. 1d). However, H&E staining revealed no difference in both groups in the classic hepatic inﬂammation features in the livers of mice administered TCDD (Fig. 2e).
Localization of SLC46A3. SLC46A3 protein was localized in the
lysosomal membrane (Fig. 2f) as revealed by lysosomes incorporated with eGFP-SLC46A3 that co-isolated with LAMP1
(Fig. 2g). The eGFP-SLC46A3 aggregated during denaturing by
boiling as revealed by western blot analysis which indicates the
marked hydrophobicity of SLC46A3, as expected from this class
of membrane-bound proteins (Fig. 2h).
Copper is a possible substrate of lysosomal SLC46A3. Based on
the color change in the liver of Slc46a3−/− mice, hepatic metal
contents were measured in WT and Slc46a3−/− mice (Supplementary Fig. 1a). Among the physiologically relevant metal ions,
copper levels were notably increased by around 30% in perfused
livers of Slc46a3−/− mice, with no differences in iron contents
(Fig. 3a and Supplementary Fig. 1b). This observation might be
due to lysosomal copper accumulation. However, liver copperrelated mRNA levels were not changed after 7 days of 10 µg/kg
TCDD (Fig. 4f). For lysosomal copper analysis, hepatic lysosomes
were isolated using magnetic beads after hydrodynamic injection
with eGFP-LAMP1 and Dsred or Dsred-SLC46A3. The lysosomal
fraction was isolated only with the N-terminal eGFP tagged
LAMP1 (Supplementary Fig. 2). Copper levels were signiﬁcantly
increased by Dsred-SLC46A3 from the isolated lysosome
(Fig. 3b). Furthermore, the 13,000 g pellet from the lysate of
Hepa1c1c7 cells had elevated FLAG-SLC46A3 protein levels
(Fig. 3c), and copper levels were signiﬁcantly increased in the
presence of copper sulfate (Fig. 3d). Based on copper analysis
using liver and cell lines, SLC46A3 may transport copper into the
lysosome. Thus, a quenching effect was tested in lysosomes using
Phen Green FL dye in the presence of recombinant SLC46A3
expression in Hepa1c1c7 cells. A quenching effect was found in
lysosomes embedded with mCherry-SLC46A3 (Fig. 3e) as
revealed by decreased levels of Phen Green ﬂuorescence in the
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Fig. 1 Regulation of Slc46a3. a Slc46a3 mRNA expression in different mouse tissues after oil (n = 3–4 per group) or TCDD (10 µg/kg for 24 h)(n = 3–4 per
group) administration. b Hepatic Slc46a3 mRNA expression after oil (n = 4 per group) or TCDD (10 µg/kg for 24 h)(n = 5 group) administration in Arnt−/−
mice. Two-way ANOVA with Bonferroni’s multiple comparisons tests, ***p < 0.0002, ****p < 0.0001. c Male mouse liver transcription proﬁling by Affymetrix
microarray (GEO: GSE55084) shows Slc46a3 mRNA after treatment with PCB-153 (IP injection, 80 mg/kg for 48 h) and TCDD (IP injection, 10 µg/kg for 48 h).
Oil (n = 6 per group), PCB-153 (n = 3 per group), TCDD (n = 3 per group). NS not signiﬁcant. d Putative DRE/XRE binding sites of Slc46a3 promoter were
extracted using ChIP-seq data (GEO accession: GSE97634) and possible enhancer region (~ −17,135 bp from the 5′-ﬂanking region of Slc46a3) was analyzed
using original ﬁle sets using Integrated Genome Browser (Bioviz). e Counting of putative dioxin-responive enhancer (DRE)/xenobiotic response element (XRE)
region (−17,135 bp of Slc46a3) binding by AhR after TCDD administration in mouse liver (n = 5 per group). The ChIP-seq data set was from Gene Expression
Omnibus (Geo, accession: GSE97634). f Luciferase assay using putative 3×DRE enhancer region (−17,135 bp) of Slc46a3 gene in the Hepa1c1c7 cells. Cells were
transfected with 3×DRE or 3×mutDRE luciferase constructs (n = 3 biologically three independent experiments) overnight and treated with indicated doses of
TCDD for 6 h. g Inhibitory effect of the AhR inhibitor, CH-223191, on the putative 3×DRE luciferase activity in Hepa1c1c7 cells. After transfection with the 3×DRE
luciferase plasmid (n = 3 biologically three independent experiments), cells were co-treated with different concentrations of CH-223191 with/without 10 nM
TCDD for 6 h. Transfection was normalized with the Renilla luciferase signal. One-way ANOVA with Tukey’s multiple comparisons test, ****p < 0.0001.
h Inhibitory effects of the AhR antagonist CH-223191 on TCDD-induced Slc46a3 mRNA in Hepa1c1c7 cells (n = 5 biologically independent samples).
i Expression of hepatic Slc46a3, Cyp1a2, and Ahr mRNAs as a function of mouse age (n=more than 6 per group). One-way ANOVA with Tukey’s multiple
comparisons test, ****p < 0.0001. j Expression of hepatic Slc46a3, Cyp1a2, and Ahr mRNAs as a function of time after TCDD treatment (n = 4 per group). Oneway ANOVA with Tukey’s multiple comparisons test, ****p < 0.0001. k Expression of Slc46a3 mRNA as a function of dose and time of oil (n = 4 per group) or
TCDD (n = 5 per group) treatment. Each data point represents the mean ± SD and adjusted p value, presented in the panels, was determined by unpaired twotailed Student’s t test using indicated sample sizes and groups.

lysosome by mCherry-SLC46A3 (Fig. 3f). This might be due to
certain metals such as copper, transferred into the lysosome.
Copper ions may be sequestered in the lysosome via SLC46A3.
To probe the lysosomal copper contents, eGFP-SLC46A3expressing Hepa1c1c7 cells were incubated with the labile
copper sensing probe CF4 (1 µM) and its non-responsive control
Ctrl-CF4 (1 µM) for 10 m and a red ﬁltered ﬂuorescence signal
detected under ﬂuorescence microscopy. The CF4 signal was
strongly detected in the eGFP-SLC46A3-embedded lysosomes
compared to Ctrl-CF4 (Fig. 3g). By high-magniﬁcation images of
eGFP-SLC46A and CF4, their sensing location was conﬁrmed
using a BZ-X analyzer. eGFP-SLC46A3 protein was localized in

the lysosomal membrane and CF4-Cu was encapsulated inside of
the lysosome (Fig. 3h, i). In addition, the lysosome size was
increased in eGFP-SLC46A3-expressing cells (Fig. 3j). To measure whether SLC46A3 could induce lysosomal copper accumulation, FLAG-SLC46A-expressing Hepa1c1c7 cells were incubated
with CF4. The CF4 signal was signiﬁcantly increased by FLAGSLC46A3 (Fig. 3k, l). As a control, the cells were treated with
different doses of CuSO4 for 10 min and followed by CF4 (1 µM)
treatment for 10 min. Fluorescence intensity of CF4 at 560 nm
was signiﬁcantly increased by CuSO4 in a dose-dependent manner (Fig. 3m). Furthermore, the protein level of the copper chaperone for superoxide dismutase (CCS), a representative
marker of the labile copper pool in the cytosol, under different
conditions was measured. CCS was signiﬁcantly increased in both

NATURE COMMUNICATIONS | (2021)12:290 | https://doi.org/10.1038/s41467-020-20461-0 | www.nature.com/naturecommunications

3

ARTICLE

NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-20461-0

Fig. 2 Generation and characterization of Slc46a3−/− mice. a Scheme for the generation of Slc46a3−/− mice. b Southern blot genotyping of Slc46a3−/−
mice using a speciﬁc probe. A representative image is shown from three wild-type (WT) and Slc46a3−/− mice. c Northern blot analysis of Slc46a3
mRNA in the livers of wild-type (WT) and Slc46a3−/− mice after treatment with TCDD (200 µg/kg) for 24 h. A representative image is shown from three
mice in each treatment group from both mouse lines. d Change in the color of the liver before and after perfusion in WT and Slc46a3−/− mice.
e Representative H&E staining of liver tissue (n = 3 images per mouse). f Localization of eGFP-SLC46A3 in the lysosomes of Hepa1c1c7 cells. A
representative ﬂorescence image was obtained from three biologically independent experiments. Blue color, nucleus; scale bar, 10 μm. g Puriﬁcation of
eGFP-SLC46A3-embedded lysosomes. IgG-L immunoglobulin light chain; IgG-H immunoglobulin heavy chain. The representative western blot image was
obtained from three independent experiments. h Western blotting of eGFP-SLC46A3 using lysates of Hepa1c1c7 cells.

TCDD-treated (10 µg/kg for 7 days) livers (Fig. 4a) and eGFPSLC46A3-expressing Hepa1c1c7 cells (Fig. 4b). Furthermore, the
effect was enhanced in the presence of BCS, a Cu (I) chelator in
the media, in the presence of eGFP-SLC46A3 expressing cells
(Fig. 4b). However, ferritin-heavy chain, a marker for the labile
cytosolic iron pool, was not changed by eGFP-SLC46A3 expression level changes in Hepa1c1c7 cells (Fig. 4c). In addition,
mitochondrial SOD activity was increased as reported previously
(Fig. 4d)10. Inversely, the hepatic CCS level was dramatically
decreased by disruption of the Slc46a3 gene in mice (Fig. 4e).
Thus, copper may be a substrate for SLC46A3 in the hepatic
lysosome.
SLC46A3 alters mitochondrial potential and morphology.
Because copper ion is a cofactor of the complex IV of the respiratory
chain, the mitochondrial morphology and mitochondrial potential
were analyzed in the presence or absence of SLC46A3. In primary
hepatocytes of Slc46a3−/− mice, mitochondria distal from the
nucleus, were thick and elongated compared to small round organelles found in WT mouse liver (Fig. 5a). The mitochondrial area of
Slc46a3−/− mice was signiﬁcantly larger than in WT hepatocytes
(Fig. 5b). The altered mitochondrial morphology was further conﬁrmed by ﬂuorescence microscopy after MitoTracker treatment
in mCherry- or mCherry-SLC46A3-expressing primary hepatocytes.
In particular, in mcherry-SLC46A3-expressing hepatocytes,
mitochondria were transformed to thin and long thread-like
4

structures associated with weak mitoTracker signals (Fig. 5c). In
this experiment, the mCherry signal was not visible because the
MitoTracker intensity overwhelms the mCherry signal. In addition,
MitoTracker intensity was notably decreased in eGFP-SLC46A3expressing Hepa1c1c7 cells (Fig. 5d). SLC46A3 induction could
inhibit mitochondrial potential in tetramethylrhodamine ethyl ester
(TMRE)-treated Hepa1c1c7 cells (Fig. 5e). Furthermore, the initial
oxygen consumption rate (OCR) was signiﬁcantly reduced in eGFPSLC46A3-expressing Hepa1c1c7 cells (Fig. 5f). As mitochondrial
potential was changed by SLC46A3 overexpression, hepatic ATP
levels were measured. ATP was signiﬁcantly decreased by overexpression of eGFP-SLC46A3 in Hepa1c1c7 cells (Fig. 5g). In addition, mitochondrial images were taken using transmission electron
microscopy (TEM) to determine whether overexpression of
SLC46A3 could change mitochondrial morphology. The mitochondrial morphology in livers of Slc46a3−/− mice were longer compared
to those in WT livers (Fig. 5h). However, a truncated or donutshaped mitochondrial form was found in livers expressing eGFPSLC46A3 (Fig. 5i).
Slc46a3−/− mice are resistant to TCDD-induced hepatic triglyceride accumulation. To investigate the possible function of
hepatic SLC46A3 after TCDD (200 µg/kg for 7 days) exposure, ALT
and ALP were measured in serum. However, a difference between
WT and Slc46a3−/− mice was not observed. Interestingly, TCDD
did not alter the hepatic triglyceride (TG) levels in Slc46a3−/− mice
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Fig. 3 Copper is a possible substrate of SLC46A3 in lysosome. a Hepatic Copper 63 (63Cu) level analysis using inductively coupled plasma mass
spectrometry (ICP-MS) in WT (n = 5 per group) and Slc46a3−/− (n = 5 per group) mice. b Relative 63Cu level in the lysosomal fraction from eGFP-Lamp/
DsRed or eGFP-Lamp/DsRed-SLC46A3-expressing mouse liver (n = 3 per group). c FLAG-SLC46A3 fractions in different centrifugal forces using
Hepa1c1c7 cells. P pellet, S supernatant. d Copper transporter assay using FLAG-SLC46A3-expressing Hepa1c1c7 cells in the presence of copper sulfate
(n = 3 biologically independent samples). e Measurement of the relative quenching effect by heavy metals using Phen Green FL dye in mcherry-SLC46A3expressing Hepa1c1c7 cells. The representative images were obtained from three independent experiments. Arrows indicate lysosomes. Scale bar, 10 μm.
f Relative green ﬂuorescence was measured relative to cytoplasmic and lysosomal locations. Cyto cytoplasm, Lyso lysosome. g Fluorescence images show
labile copper-sensing probe CF4 localized in the eGFP-SLC46A3 embedding lysosomes in Hepa1c1c7 cells. Ctrl-CF4 probe was used as a control. All
images were pictured under the same conditions. The representative images were obtained from three independent experiments. Scale bar, 10 µm. h A
model of copper-encapsulated lysosome with eGFP-SLC46A3 was depicted. The representative images were obtained from three independent
experiments. i Locations of eGFP-SLC46A3 and Cu-CF4 were presented with the brightness of each color from the section (a to b) of two neighboring
lysosomes. j Lysosomal sizes were measured in the presence of eGFP or eGFP-SLC46A3 in Hepa1c1c7 cells. k Hepa1c1c7 cells were transfected with FLAGSLC46A and incubated with CF4 (1 µM) for 10 m. Red ﬂuorescence color indicates Cu-CF4 complex. The representative images were obtained from three
independent experiments. Scale bar, 10 μm. l The Red-light intensity was measured using a ﬂuorescence plate reader (Ex. 540/Em 560). m To control the
CF4-Cu sensing experiment, Hepa1c1c7 cells were treated with different doses of CuSO4 for 10 m and incubated with CF4 (1 µM) for 10 m. The CF4
emission light was read using a ﬂuorescence plate reader (Ex. 540/Em 560). Each data point represents the mean ± SD and adjusted p value, presented in
the panels, was determined by unpaired two-tailed Student’s t test using indicated sample sizes and groups.

compared to WT mice. In addition, differences in levels of hepatic
free fatty acids (non-esteriﬁed fatty acid, NEFA) were not observed
between both groups in the presence or absence of TCDD (Fig. 6a).
Oil red O staining revealed that lipid droplet accumulation in livers
of TCDD-treated Slc46a3−/− mice were signiﬁcantly reduced
compared to WT mice (Fig. 6b). Since Slc46a3−/− mice were
resistant to TCDD-induced TG accumulation in the liver, a high-fat
diet (HFD) model was applied to determine whether Slc46a3−/−
mice were resistant to hepatic TG accumulation. Notably, after
3 weeks of HFD feeding, body weight changes in Slc46a3−/− mice
were signiﬁcantly reduced compared to WT mice (Fig. 6c). Glucose
tolerance test (GTT) showed no signiﬁcant difference between WT
and Slc46a3−/− mice (Supplementary Fig. 3). In addition, liver mass

and epididymal fat mass were also lower in Slc46a3−/− than in WT
livers (Fig. 6d, e). Hepatic TG levels were lower in Slc46a3−/− after
HFD feeding compared to WT mice. Conversely, hepatic NEFA
levels were higher in Slc46a3−/− mice than in WT mice (Fig. 6f),
while differences in serum TG and NEFA levels in the two groups
were not observed (Fig. 6g). These results suggest that SLC46A3
inﬂuences hepatic TG generation from NEFA in the liver. Due to
the change of hepatic TG levels in Slc46a3−/− mice, lipid metabolites were analyzed in livers from WT and Slc46a3−/− mice. Two
peaks from 16.88 min were signiﬁcantly changed (Supplementary
Fig. 4a). PLS-DA (Supplementary Fig. 4b) and S-plots (Supplementary Fig. 4c) using UPLC-MS data by SIMCA-P + 12 software,
as well as GC-MS analysis with the FAME-derivatization method,
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Fig. 4 TCDD and eGFP-SLC46A3 increases the copper chaperone for superoxide dismutase. a Western blotting data show the level of copper-related
proteins in the liver after oil (n = 5 per group) or TCDD (10 μg/kg for 7 days) treatment (n = 5 per group). Densitometrical analysis is shown in the right
panel. b Western blotting data show the level of copper chaperone for superoxide dismutase (CCS) protein level after treatment with BCS (Cu (I) chelator
in the media) for 3 days in the presence of eGFP-SLC46A3 in Hepa1c1c cells. Densitometrical analysis is shown in the right panel. NB nonboiled sample.
c The level of heavy chain of ferritin, an indicator of labile cytoplasmic iron levels, was measured after induction of eGFP-SLC46A3 in Hepa1c1c7 cells.
d SOD activity was measured when Hepa1c1c7 cells were treated with different doses of BCS in the presence of eGFP-SLC46A3. e Western blotting data
show the level of copper chaperone for superoxide dismutase (CCS) in the livers from wild-type (WT)(n = 4 per group) and Slc46a3−/− mice (n = 4 per
group). Densitometrical analysis is shown in the right panel. f Expression of mRNAs encoding metal transporters in the mice liver after oil (n = 4 per group)
or TCDD (10 µg/kg for 24 h) (n = 5 per group) administration. Each data point represents the mean ± SD and adjusted p value, presented in the panels,
was determined by unpaired two-tailed Student’s t test using indicated sample sizes and groups.

revealed two ions [16:0/18:1/18:2] and TG [16:0/18:2/ 18:2] as TG
(Supplementary Fig. 4d). Thus, hepatic levels of Acadm, Acox1,
Fasn, Acc1, Scd1, Lcat, Cd36, Hsl, Pnpla2, Aadac, Tgh, Mttp, Dgat1,
Dgat2, Fsp27, and Plin2 mRNAs encoding TG/NEFA-related proteins were measured. However, no difference between WT and
Slc46a3−/− in their expression levels was found under the condition
of both vehicle and TCDD treatment (Fig. 6h).
Slc46a3 induction triggers hepatic triglyceride accumulation.
Since the phenotype of the Slc46a3−/− mice revealed that
SLC46A3 affected hepatic TG accumulation, a direct role for
SLC46A3 in lipid accumulation was investigated. Forced expression of SLC46A3 in the liver by both adenovirus and hydrodynamic sheer injection signiﬁcantly increased hepatic lipids
(Fig. 7a) and TGs (Fig. 7b). Since adipophilin (ADFP) is expressed
in lipid droplets in concert with TG accumulation, Adfp mRNA
levels were measured after Ad-SLC46A3 administration for 7 days.
Hepatic Adfp mRNA was signiﬁcantly increased by Ad-SLC46A3
administration (Fig. 7c). In addition, mCherry-SLC46A3 increased
the size of eGFP-ADFP-expressing lipid droplets in primary
hepatocytes (Fig. 7d, e). The increase of lipid droplet size by
SLC46A3 was conﬁrmed by Nile Red staining in primary
6

hepatocytes (Fig. 7f). In addition, lipid droplets were increased by
tetraethylenepentamine (TEPT), a copper chelator, in Hepa1c1c7
cells (Supplementary Fig. 5). Furthermore, SLC46A3 could alter
the phosphorylation of some energy homeostasis-related proteins
such as APMKα and ACC. Ad-SLC46A3 increased phosphorylation of AMPKα and decreased phosphorylation of ACC in a titerdependent manner in primary hepatocytes (Fig. 7g). Thus,
SLC46A3 induction may cause unbalanced energy homeostasis.
Discussion
Here, the function of SLC46A3 was analyzed in mouse liver.
Because SLC46A3 is speciﬁcally induced by TCDD in liver via
AhR signaling, it might play an important role in liver pathophysiology, notably in the toxic response to TCDD. To investigate
the function of SLC46A3, Slc46a3−/− mice were generated. The
critical gross pathological feature of Slc46a3−/− mice was gray
rather than yellow livers as compared to WT mice. Metal ions
were measured in the liver to investigate whether the color change
was the result of altered levels of intracellular metal ions. Interestingly, copper and iron were increased in the liver. For iron, no
signiﬁcant difference was noted after liver perfusion as well as in
the 13,000 g fraction of the eGFP-SLC46A3-expressing liver
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Fig. 5 Slc46a3 affects mitochondrial potential and morphology. a Fluorescence images of mitoTracker in the primary hepatocytes. Red color, mitochondria;
blue color, nucleus; scale bar, 10 μm. The representative images were obtained from three independent experiments. b Relative mitochondrial sizes between WT
and Slc46a3−/−. c MitoTracker intensity in the primary hepatocytes in the presence or absence of mCherry-SLC46A3. The representative images were obtained
from three independent experiments. N nucleus; scale bar, 10 μm. d MitoTracker intensity in the eGFP-SLC46A3-expressing Hepa1c1c7 cells. Scale bar, 10 μm; blue
color, nucleus. The representative images were obtained from three independent experiments. e Mitochondrial potential images with TMRE dye in Hepa1c1c7 cells.
The asterisk indicates the same location. The representative images were obtained from three independent experiments. f Mitochondrial oxygen consumption rate
(OCR) in eGFP-SLC46A3-expressing Hepa1c1c1 cells. g Relative ATP levels were measured in the eGFP-SLC46A3-expressing Hep1c1c7 cells. h Transmission
electron microscopy (TEM) images of hepatocytes in WT (n = 3 per group) and Slc46a3−/− (n = 3 per group) mice. m mitochondria; scale bar, 500 nm. The
representative images were obtained from three biologically independent liver samples. i TEM images of hepatocytes in eGFP-SLC46A3-expressing liver. The
representative images were obtained from three biologically independent liver samples. ld lipid droplet, dm donut shape mitochondria, m mitochondria; scale bar,
500 nm. Each data point represents the mean ± SD and the adjusted p value, presented in the panels, was determined by unpaired two-tailed Student’s t test using
indicated sample sizes and groups.

(Supplementary Fig. 6). This may be due to an increase in iron in
the blood. In this study, the relationship between copper ion and
SLC46A3 in the liver was investigated. Because SLC46A3 was
localized in the lysosome, the isolated lysosome fraction was
subjected to metal analysis using inductively coupled plasma mass
spectrometry (ICP-MS). These results suggested that copper
could be a possible substrate of SLC463A3.
Lysosomes are catabolic organelles in eukaryotic cells that digest
various components from the cytoplasm. Previous reports suggested
that copper can be transported to hepatocytes through vesicle pathways and can be excreted into the bile by lysosomes11,12. Lysosomes
were enlarged by SLC46A3 expression, however, the mechanism is
not known. SLC46A3 may inﬂuence the recruitment of functional
proteins for lysosomal activation such as LAMP1. Misregulated or
mutant lysosomal membrane protein-coding genes can cause human
diseases. For example, a mutation in MCOLN1 encoding mucolipin1, a lysosomal cation channel for ions such as Na+, K+, Ca2+, Fe2+,

causes mucolipidosis type IV13. As SLC46A3 protein could modulate
lysosomal copper, unbalanced intracellular copper levels in lysosomes
can lead to altered metabolic pathways as well as other metal-related
transporting systems in the liver. Increased copper levels as a result
of TCDD administration or SLC46A3 overexpression/deletion could
inﬂuence the expression of copper-related genes or other metal
concentrations in the cells. Iron-related gene mRNAs (Trf, Tfrc, Tth1,
and Ftl1), zinc-related gene mRNAs (Zip5, Zip14, Znt9, and Zint7),
and copper-related gene mRNAs (Ctr1, Atp7a, ATp7b, Ccs, and Cp)
were measured and only Ftl1 mRNA was slightly increased by TCDD
in the liver. This suggests that copper deﬁciency may trigger the
increase of iron level as a compensatory mechanism. However,
hepatic mRNA levels of zinc or copper-related proteins were
unchanged after TCDD administration.
Copper is an essential transition metal that acts as a cofactor in
many enzymes and plays an important role in cellular metabolism
and bioenergy. Importantly, copper ion is a cofactor for
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Fig. 6 TCDD induces accumulation of hepatic triglyceride through SLC46A3. a Measurements of hepatic triglyceride (TG) and non-esteriﬁed fatty acid
(NEFA) as well as serum ALT activity and serum ALP activity (n = 4 for WT-OIL group; n = 5 for other groups). Two-way ANOVA with Bonferroni’s multiple
comparisons test, **p = 0.0062; NS not signiﬁcant. b Representative Oil O Red staining of liver tissue. c Body weight changes after high-fat diet WT (n = 4 per
group) and Slc46a3−/− (n = 3 per group) mice. d Liver mass to body weight after high-fat diet in WT (n = 4 per group) and Slc46a3−/− (n = 3 per group) mice.
e Epididymal fat mass after high-fat diet in WT (n = 5 per group) and Slc46a3−/− (n = 3 per group) mice. f Hepatic TG and NEFA levels after high-fat diet in WT
(n = 3 per group) and Slc46a3−/− (n = 5 per group) mice. g TG and NEFA levels in the serum after high-fat diet in WT (n = 4 per group) and Slc46a3−/− (n = 4
per group) mice. NS not signiﬁcant. h Hepatic mRNA expressions of lipid-related metabolizing genes by oil or TCDD (10 µg/kg for 24 h) in WT and Slc46a3−/−
mice. Two-way ANOVA with Bonferroni’s multiple comparisons test, ****p < 0.0001. The sample sizes of WT-OIL, WT-TCDD Slc46a3−/−-OIL, and Slc46a3−/−
-TCDD are n = 4, 5, 5, 5 mice per group, respectively. Each data point represents the mean ± SD and the adjusted p value, presented in the panels, was
determined by unpaired two-tailed Student’s t test using indicated sample sizes and groups.

mitochondrial respiratory complex IV and cytochrome c oxidase,
and thus intracellular copper deﬁciency may cause mitochondrial
dysfunction14–17. Features of impaired copper metabolism lead to
genetic disorders such as Wilson’s and Menkes disease14–16,18.
Moreover, copper regulates the lipolysis of triglycerides via cAMP
signaling19. Therefore, in the absence of SLC46A3, the levels of
copper in the cells could be increased and mitochondrial function
would be increased as well. Conversely, induction of SLC46A3 could
lead to copper deﬁciency, since copper could migrate to the lysosome
for excretion. Indeed, previous results show that hepatic copper
deﬁciency appears at the early stages of HFD feeding20. According to
a previous report21, ATP7B, which results in Wilson’s disease,
removes excess copper into the bile via lysosomal exocytosis. Thus,
lysosomal SLC46A3 trafﬁcking is critical to understand copper
deﬁciency in hepatocytes. As a conventional method for detecting
copper accumulation in the liver, rhodanine staining was used and
copper staining was noted in Slc46a3−/− mice. Because copper was
8

increased by about 30% in the liver of Slc46a3−/− mice, copper levels
were measured in isolated lysosomes using ICP-MS analysis. Copper
accumulation was also measured in SLC46A3-embedded lysosomes
by using the copper sensing probe CF4. Based on this study, the
characteristics of mitochondria differed according to the levels of
SLC46A3. As expected, intracellular copper deﬁciency resulted in
inhibition of mitochondrial potential when SLC46A3 was overexpressed. This result is supported by a previous report that mitochondrial potential is signiﬁcantly reduced by TCDD in rat
hepatocytes22. In addition, in a previous, study the morphology of
some mitochondria was changed by copper deﬁciency to a donut
shape in human hepatocytes23 as well as the thymus and spleen in
mice24. In addition, others reported that mitochondria were changed
to a donut shape by carbonyl cyanide m-chlorophenyl hydrazine
(CCCP), a mitochondrial oxidative phosphorylation uncoupler,
without fusion or ﬁssion in MEF cells25. This morphological feature
was similar to the present result in a fusion- or ﬁssion-independent
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Fig. 7 SLC46A3 overexpression triggers TG accumulation in the liver. a Oil Red O staining after adenovirus-based (upper, n = 5 per group) and
hydrodynamic injection-based (lower, n = 3 per group) expression of Slc46a3 mRNA in the liver. b Hepatic Slc46a3 mRNA expression (left) and TG level (right)
after administration of Ad-eGFP-Cre (n = 3 mice per group) or Ad-Slc46a3 (n = 5–6 mice per group). c Hepatic Adfp mRNA expression after Ad-Slc46a3 and control
Ad-Cre administration (n = 3 per each group). d Representative ﬂuorescence images in the eGFP-adipophilin/mcherry-SLC46A3-expressing primary hepatocytes.
The representative images were obtained from three biologically independent experiments. Scale bar, 10 μm; N nucleus (blue color). e Relative volume of lipid
droplets in the eGFP (n = 11 counts per cell) or eGFP-SLC46A3 (n = 32 counts per cell) expressing primary hepatocytes from (d). f Nile Red staining after
adenoviral induction of SCL46A3 in primary hepatocytes with Ad-Slc46a3. The representative ﬂuorescence images were obtained from three biologically
independent experiments. Scale bar, 10 μm. g Western blotting of phosphorylated AMPKα and ACC using the mice liver after viral induction of Ad-Cre-GFP or AdCre-Slc46a3. The representative western blot images were obtained from three biologically independent experiments. Each data point represents the mean ± SD
and the adjusted p value, presented in the panels, was determined by unpaired two-tailed Student’s t test using indicated sample sizes and groups.

manner by the level of SLC46A3. Thus, SLC46A-induced copper
deﬁciency might lead to mitochondrial dysfunction. Later, TG could
accumulate in the liver after the reduction in mitochondrial function.
In addition, copper may affect hepatic autophagy26. However,
changes of LC3 were not found in the absence of SLC46A3.
High TG has been linked to atherosclerosis and heart disease in
humans. Under normal circumstances, an excessive amount of TG
can be stored in the form of lipid droplets and later used as an
energy source27. However, abnormal TG accumulation caused by
SLC46A3-induced mitochondrial dysfunction can cause serious
pathophysiological problems. In a previous study, hepatic TG levels
were dramatically increased by copper deﬁciency in rats28. Therefore, intracellular copper levels could play an important role in lipid
metabolism in conjunction with mitochondria function. TCDD
treatment-induced mRNA expression of some TG/NEFA-related
proteins. However, the induction was not SLC46A3-dependent, and
could not explain the SLC46A3-dependent TG accumulation in the
liver. Induction of hepatic SLC46A3 increased phosphorylation of
AMPKα and decreased phosphorylation of ACC. These data indicate the SLC46A3 can cause mitochondrial dysfunction and energy
deﬁciency in hepatocytes. In conclusion, TG accumulation by
TCDD is induced by the induction of lysosome SLC46A3, which
causes mitochondrial dysfunction by intracellular copper deﬁciency
leading to hepatic steatosis (Fig. 8).
Methods
Chemicals. TCDD was purchased from Cambridge Isotope (Andover, MA). Antiphospho-AMPKα (#2535), anti-AMPK (#2532), anti-phospho-ACC (#11818),

anti-ACC (#3676), anti-VDAC (#4661 T), anti-COX IV (#4850), anti-Ferritin (#sc376594), anti-LC3 (#2775), anti-OPA1(#80471), and anti-mouse IgG, HRP-linked
secondary antibody (#7076 S), anti-rabbit IgG, and HRP-linked secondary antibody
(#7074 S) were obtained from Cell Signaling Technology (Beverly, MA, USA). AntiGAPDH (#sc-47724), anti-CCS (#sc-374205), anti-Drp1 (#sc-271583), and anti-GFP
antibody (#sc-9996) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Anti-FLAG antibody (#F1804), bathocuproinedisulfonic acid (BCS), and other
chemicals were obtained from Sigma-Aldrich (St. Louis, MO). Nile Red, Mitotracker,
and Phen Green FL were purchased from Invitrogen (Carlsbad, CA). JetPEI transfection reagent was obtained from VWR International (Radnor, PA, USA). AntiMitofusin2 (#ab56889), TMRE, and superoxide dismutase (SOD) kit were purchased
from Abcam (Cambridge, MA). CH-223191 was obtained from Tocris (Bristol, UK).
TransIT-QR Hydrodynamic Delivery Solution was purchased from Mirus (Pittsburgh,
PA, USA). EZ-ATP Assay kit was obtained from DoGenBio (Seoul, Korea). All other
chemicals were of the highest grade commercially available. CF4 and Ctrl-CF4 were
synthesized as previously reported29.

Animals and treatments. All animal experiments were conducted in accordance with
the Association for Assessment and Accreditation of Laboratory Animal Care international guidelines and approved by the US National Cancer Institute Animal Care and
Use Committee. Slc46a3−/− mice were generated by disruption of exons 3 and 4 and
interbred with heterozygotes to obtain wild-type (WT) littermate (C57BL/6NCr and
FVB/N mixed background). Ahr−/− (ref. 30), Arntﬂ/ﬂ (ref. 31) mice were described in
earlier papers. ArntΔLiv mice were obtained by crossing the Arntﬂ/ﬂ mice with mice
carrying the Cre transgene under the control of the rat serum albumin gene
promoter32,33. C57BL/6 J mice were obtained from the Jackson Laboratory (Bar Harbor,
ME). All of the mice were maintained under a standard 12 h light/dark cycle with water
and chow provided ad libitum. For genotyping of Slc46a3−/− mice, mouse tails were
subjected to general PCR using speciﬁcally designed primers: FJG99-1stloxp-F3, 5′-CC
TCGAGGGACCTAATAACTTC-3′, FJG99-15030-F, 5′-GCACTGAGACA
CCATTGTGACGCC-3′, and FJG99-15514-R, 5′-AGCAAAGGTCCGCTTAGTTA
GAGAC-3′. A PCR amplicon (~400 bp) was indicated as Slc46a3−/− mice. To investigate the potential role of SLC46A3 in TCDD-induced liver injury, mice were injected
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Fig. 8 Scheme showing a possible role of SLC46A3 in hepatic lipid accumulation in mice. In the normal state of hepatocytes, intracellular copper levels can
be balanced by homeostasis, but induction of SLC46A3 by TCDD can lead to an abnormal increase in copper migration to lysosomes. Conversely, a mild increase
of copper in the cytosol may inhibit TG accumulation in liver. Thus, the lack of intracellular copper levels can result in mitochondrial dysfunction. Ultimately, lipids
such as TG are stored in the form of lipid droplets. Nu Nucleus; Mito Mitochondria; Ly Lysosome; SLC SLC46A3; Cu Copper; Ld Lipid droplet; Bc Bile canaliculi.
intraperitoneally with a single dose of 10 or 200 μg/kg of TCDD for 3 or 7 days. To
investigate a role for SLC46A3 in hepatic TG accumulation, mice were fed a 60% of
HFD that was obtained from Research Diets (New Brunswick, NJ). Six weeks later, the
mice were killed.
Cell culture. Hepa1c1c7 cells were purchased from the ATCC and cultured in DMEM
supplemented with 10% heat-inactivated FBS and 50 U/ml of penicillin/streptomycin
mixture (Invitrogen) at 37°C in a humidiﬁed atmosphere of 5% CO2/95% air. Cells were
grown to 60–80% conﬂuence and trypsinized with 0.05% trypsin containing 2 mM
EDTA. For ectopic expression of proteins in hepatocytes, recombinant adenovirus or
hydrodynamic shear plasmid DNA was delivered to the liver using tail vein injection.
Primary hepatocytes were cultured overnight and treated with 20 nM MitoTracker or
0.5 μg/ml Nile Red for 15–30 m.
Plasmids. For mammalian expression, coding regions for mouse Slc46a3, Adfp, and
Lamp1 cDNAs were subcloned into pEGFP, pDsred, and pmCherry plasmids (Clontech, Mountain View, CA, USA) for tagging eGFP, Dsred, and mCherry, respectively, at
the N-terminal of the SLC46A3 protein. For the FLAG-SLC46A3-expressing plasmid
(pCMV-Flag-Slc46a3), the EGFP cDNA in the pEGFP plasmid was replaced to make
the ﬁnal Flag-Slc46a3 fusion gene by modiﬁcation.
In vivo and in vitro DNA delivery. For in vivo plasmid DNA delivery, hydrodynamic shear tail vein injection was carried out using 10-week-old C57BL/6 J male
mice. Mixtures with pEGFP-Slc46a3 (20 μg) or pmCherry-Slc46a3 (20 μg) or pEGFPAdipophilin (10 μg) and 2.2 ml of TransIT-QR delivery solution were injected within 3
to 5 s through the tail vein. One day later, the mice were killed or primary hepatocytes
isolated for culturing as previously described34. Using small pieces of fresh liver,
the expression of each ﬂuorescence fusion protein was monitored under ﬂuorescence
microscopy. Adenoviral delivery of SLC46A3 using 10-week-old C57BL/6 J male mice
was carried out by injecting 200 μl of saline solution containing 2 × 1010 pfu/mouse
through the tail vein. A week later, the mice were killed. For in vitro transfection,
Hepa1c1c7 cells were transfected with different plasmids using JetPEI reagent for 16 h
before the cells were harvested.
Quantitation of mRNA. Total RNA was isolated from the liver using Trizol (Invitrogen, Carlsbad, CA). After synthesis of complementary DNA (cDNA) using a
SuperScript II reverse transcriptase kit (Invitrogen, Carlsbad, CA), qPCR was carried
out using an Applied Biosystems Prism 7900HT Sequence Detection System (Foster
City, CA) as described previously35. Expression levels of mRNA were normalized to
18 S RNA or Gapdh mRNA as the internal standards. Primers for the qPCR are listed in
Supplementary Table 1.
Western blotting. Hepa1c1c7 cells were lysed with M-PER buffer (Thermo Scientiﬁc)
or RIPA lysis buffer (150 mM NaCl, 0.5% Triton X-100, 50 mM Tris–HCl, pH 7.4,
25 mM NaF, 20 mM EGTA, 1 mM DTT, 1 mM Na3VO4, and protease inhibitor
cocktail) for 30 min on ice, followed by differential centrifugal for fractionation. Protein
concentration was measured with the bicinchoninic acid (BCA) reagent. Protein
(10–30 µg), denatured by boiling and unboiled control, was subjected to electrophoresis
on a 4–15% gradient Tris-HCl gel (Bio-Rad, Hercules, CA) and then electrotransferred
onto a polyvinylidene diﬂuoride membrane in Tris-glycine buffer (pH 8.4) containing
20% methanol. The membrane was blocked with 5% fat-free dry milk in phosphatebuffered saline containing 0.1% Tween-20 (PBST) for 1 h. The membranes were probed
with primary antibodies and horseradish peroxidase-conjugated secondary antibodies
(#7074 S, #7076 S, Cell Signaling) using standard western blotting procedures. Secondary antibodies were diluted at 1:5000 for the experiments. Proteins were visualized
using the Femto signal chemiluminescent substrate (Pierce) by an image analyzer
(Alpha Innotech Corp., San Leandro, CA) or a Chemidoc imaging system (Bio-Rad).
Protein densitometry analyses were performed using Image Lab 6.1.1 software (Biorad).
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Mitochondria analysis. For mitochondrial OCR measurements, Hepa1c1c7 cells were
cultured in specialized 24-well plates and transfected with 100 μg of pEGFP or pEGFPSlc46a3 plasmid for 24 h and mitochondrial OCR measured using the Seahorse XF24
analyzer as described previously36. OCR was measured from the basal conditions and
later cells were treated with the mitochondrial inhibitor oligomycin, a mitochondrial
uncoupling compound carbonylcyanide-4-triﬂuoromethoxyphenylhydrazone (FCCP),
and the respiratory chain inhibitor antimycin A.
Biochemical analysis. Serum levels of alanine aminotransferase (ALT) and alkaline
phosphatase (ALP) were measured using ALT (Catachem, Bridgeport) and ALP kits
(Catachem, Bridgeport). Serum or hepatic level of non-esteriﬁed fatty acids (NEFA) and
hepatic TG level were quantiﬁed using TG kit (Wako Chemicals USA Inc.) and NEFA
kit (Wako Chemicals USA Inc.) according to the manufacturer’s instructions.
Metal analysis in the liver. Liver tissues and isolated cell fractions were treated with
100% nitric acid at 70 °C for 3 h and then incubated overnight at room temperature.
Levels of major physiological metal ions were measured by inductively-coupled plasma
(ICP)-MS (Agilent, Model 7500 cs) as described previously37.
Copper transport assay. To analyze the copper levels in the lysosomal fraction,
hepatic lysosomal fraction was isolated using the magnetic bead method. In detail, 8week-old FVB male mice were transfected with pEGFP-Lamp1 (10 μg) and pDsredSlc46a3 (10 μg) or pDsred (10 μg) using the hydrodynamic injection method for 24 h.
Liver tissue (300 mg) was homogenized with a tight dounce homogenizer in the presence of 0.1 M Tris-HCl buffer containing protease inhibitor cocktail followed by
centrifugation at 100×g at 4°C for 5 min twice. The supernatants were incubated with
biotinylated anti-GFP antibody (20 μg/1 ml) for 20 m at 4°C using a rotary shaker and
the lysosomes-eGFP-Lamp1 complex was isolated with a streptavidin-magnetic bead
(Pierce). The isolated lysosomal fractions were subjected to western blotting or metal
analysis.
For in vitro metal transport assays, Hepa1c1c7 cells were transfected with different
amounts of pCMV-Flag-Slc46a3 plasmid using JetPEI transfection reagent for 24 h. The
cells were then treated with copper sulfate (CuSO4·5H2O, 10 μg/ml) in serum-free
DMEM media for 1 h. After extra incubation of cells in fresh serum-free DMEM for
30 m, the cells were lysed with M-PER buffer, and subjected to sequential fractionation
by differential centrifugal at 800 g for 5 m, 13,000×g for 10 min, or 543,000×g for 30 min
at 4°C. Each pellet or supernatant were subjected to western blotting and metal analysis.
Reporter gene assays. To verify the role of AhR on Slc46a3 regulation, the putative
DRE site (−17 kb) of Slc46a3 was inserted in pGL4.10 with additional minimal TATA
box sequence using AscI/PacI sites. pGL4.10-3×DREmini was depicted as wild-type and
pGL4.10-3×mutDREmini was indicated as mutant as an experimental control. The
inserted sequences for pGL4.10-3×DREmini and pGL4.10-3×mutDREmini are GGAG
ATAGCGTGCCATGGTCTGCCTGGAGATAGCGTGCCATGGTCTGTTTGGAGA
TAGCGTGCCATGGTCTGAGACACTAGAGGGTATATAATGGAAG CTCGACTT
CCAGCT and TGGAGATAAAAAACCATGGTCTGCCTGGAGATAAAAAACCAT
GGTCTGTTTGGAGATAAAAAACCATGGTCTGAGACACTAGAGGGTATATAA
TGGAAGCTC GACTTCCAGCT, respectively. Hepa1c1c7 cells were transfected with
the plasmids overnight using JetPEI reagent and treated with 10 nM TCDD for 6 h in
the presence or absence of the AhR inhibitor CH-223191. The dual-luciferase assay was
conducted using the Promega dual luciferase system. Renilla luciferase activity was used
as transfection control.
Histology. For microscopic examination, fresh livers were ﬁxed in 10% buffered formalin and embedded with parafﬁn. Tissue sections (4 µm) were stained with hematoxylin and eosin (HE) (Sigma-Aldrich, St. Louis, MO, USA). Frozen liver tissues were
cut at 10 µm thickness and stained with Oil Red O to detect lipid droplets.
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Transmission electron microscopy (TEM). TEM images of livers were serviced by
the Center for Cancer Research (CCR) of NCI at Frederick.
Southern blot analysis: Tail DNA from the WT and Slc46a3−/− mice was
performed as described previously38 using speciﬁc probes (Supplementary Table 1).
Northern blot analysis: Total RNA from different tissue samples was prepared
by using Trizol reagent (Invitrogen, Carlsbad, CA). Northern blot analyses were
performed as previously described31. Slc46a3 cDNA (901 bp) was used as a
Northern probe.
ATP measurement. Hepa1c1c7 cells were transfected with pEGFP (8 µg) or
pEGFP-Slc46a3 (8 µg) plasmids in 100 mm dishes overnight and cell lysates
and ATP was measured according to the manufacturer’s instructions
(DoGenBio, Seoul, Korea).
Statistical analysis. Experimental values are expressed as mean ± SD. Statistical
analysis was performed by one-way ANOVA for multiple comparisons using
Tukey’s multiple comparisons test, two-way ANOVA for comparisons of multi
factors using Bonferroni’s method, or two-tailed Student’s t test for unpaired data.
P < 0.05 was considered statistically signiﬁcant. GraphPad PRISM v.8.4.3 was used
for statistical analysis.

Data availability
All relevant data are available from the corresponding authors upon request. Source
data are provided with this paper. Supplementary information is provided in
Supplementary Figs. 1–9, Supplementary Table 1. The mouse liver transcription
proﬁling by array for Fig. 1c was downloaded from Gene Expression Omnibus under
the accession code GSE55084 and AhR ChIP-seq data in Fig. 1d was downloaded from
Gene Expression Omnibus under the accession code GSE97634. Source data are
provided with this paper.
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